The Scientist

» industry

Most Recent

image: Opinion: Tales from the Nonacademic Career Path

Opinion: Tales from the Nonacademic Career Path

By | September 3, 2017

Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

image: Life Science Leaders Meet at White House

Life Science Leaders Meet at White House

By | May 8, 2017

Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.

0 Comments

image: National Academies Revise Conflict of Interest Policy

National Academies Revise Conflict of Interest Policy

By | May 3, 2017

The proposed changes follow revelations in recent years that committee members preparing reports for the Academies did not disclose industry relationships. 

2 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Addressing Biomedical Science’s PhD Problem

Addressing Biomedical Science’s PhD Problem

By | January 1, 2017

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

9 Comments

image: Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies

Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies

By | December 21, 2016

Two opposing papers in Annals of Internal Medicine battle over dietary guidelines on sugar.

3 Comments

image: 2016 Salary Survey: By the Numbers

2016 Salary Survey: By the Numbers

By | November 1, 2016

This year's life sciences salary survey turned up some interesting trends in the U.S. and around the world.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS